Angiomyomatous hamartoma of lymph nodes, revisited: clinicopathologic study of 21 cases, emphasizing its distinction from lymphangioleiomyomatosis of lymph nodes.

Moh, Michelle; Sangoi, Ankur R; Rabban, Joseph T

Moh, Michelle; Sangoi, Ankur R; Rabban, Joseph T.

Affiliation

Moh M; Department of Pathology, University of California San Francisco, San Francisco, CA 94158.
Sangoi AR; Department of Pathology, El Camino Hospital, Mountain View, CA 94158.
Rabban JT; Department of Pathology, University of California San Francisco, San Francisco, CA 94158. Electronic address: joseph.rabban@ucsf.edu.

Hum Pathol ; 68: 175-183, 2017 10.

Article in En | MEDLINE | ID: mdl-28899738

Subject(s)

Hamartoma/pathology; Lymph Nodes/pathology; Lymphangioleiomyomatosis/pathology; Lymphoproliferative Disorders/pathology; Adult; Aged; Aged, 80 and over; Biomarkers, Tumor/analysis; Biopsy; Cathepsin K/analysis; Diagnosis, Differential; Female; Hamartoma/enzymology; Humans; Immunohistochemistry; Lymph Nodes/enzymology; Lymphoproliferative Disorders/enzymology; Male; Melanoma-Specific Antigens/analysis; Middle Aged; Predictive Value of Tests; Young Adult; gp100 Melanoma Antigen

Key words

Angiomyomatous hamartoma; Cathepsin K; HMB-45; Lymph node; Lymphangioleiomyomatosis

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Database: MEDLINE Main subject: Lymphangioleiomyomatosis / Hamartoma / Lymph Nodes / Lymphoproliferative Disorders Type of study: Diagnostic_studies / Prognostic_studies Limits: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Year: 2017 Type: Article

Fulltext

XML

PubMed Links

Search on Google